Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Layden

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 1, 2017
Increased risk of PTLD in lung transplant recipients with cystic fibrosisErin M Lowery, William Adams, Shellee A Grim, et al.
Clinical Transplantation|April 30, 2013
The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantationJulie Rowe, Shellee A Grim, David Peace, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2012
Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolidElena M Santayana, Shellee A Grim, William M Janda, et al.
Journal of Viral Hepatitis|September 13, 2002
Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis CThomas J Layden, Jennifer E Layden, K Rajender Reddy, et al.
Journal of Viral Hepatitis|September 13, 2002
First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral declineJennifer E Layden, Thomas J Layden, K Rajender Reddy, et al.
Transplantation|January 27, 2012
Impact of donor and recipient race on survival after hepatitis C-related liver transplantationJennifer E Layden, Scott J Cotler, Shellee A Grim, et al.
JMIR Public Health and Surveillance|May 11, 2022
A Standard-Based Citywide Health Information Exchange for Public Health in Response to COVID-19: Development StudyBala Hota, Paul Casey, Anne F McIntyre, et al.
The Journal of Antimicrobial Chemotherapy|December 21, 2011
Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomesShellee A Grim, Karen Berger, Christine Teng, et al.
MMWR. Morbidity and Mortality Weekly Report|November 15, 2019
Risk Factors for E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products - Illinois, July-October 2019Livia Navon, Christopher M Jones, Isaac Ghinai, et al.
Gastroenterology|February 12, 2009
A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver diseaseHarel Dahari, Jennifer E Layden-Almer, Eric Kallwitz, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 1, 2017
Increased risk of PTLD in lung transplant recipients with cystic fibrosisErin M Lowery, William Adams, Shellee A Grim, et al.
Clinical Transplantation|April 30, 2013
The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantationJulie Rowe, Shellee A Grim, David Peace, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2012
Risk factors and outcomes associated with vancomycin-resistant Enterococcus infections with reduced susceptibilities to linezolidElena M Santayana, Shellee A Grim, William M Janda, et al.
Journal of Viral Hepatitis|September 13, 2002
Induction therapy with consensus interferon (CIFN) does not improve sustained virologic response in chronic hepatitis CThomas J Layden, Jennifer E Layden, K Rajender Reddy, et al.
Journal of Viral Hepatitis|September 13, 2002
First phase viral kinetic parameters as predictors of treatment response and their influence on the second phase viral declineJennifer E Layden, Thomas J Layden, K Rajender Reddy, et al.
Transplantation|January 27, 2012
Impact of donor and recipient race on survival after hepatitis C-related liver transplantationJennifer E Layden, Scott J Cotler, Shellee A Grim, et al.
JMIR Public Health and Surveillance|May 11, 2022
A Standard-Based Citywide Health Information Exchange for Public Health in Response to COVID-19: Development StudyBala Hota, Paul Casey, Anne F McIntyre, et al.
The Journal of Antimicrobial Chemotherapy|December 21, 2011
Timing of susceptibility-based antifungal drug administration in patients with Candida bloodstream infection: correlation with outcomesShellee A Grim, Karen Berger, Christine Teng, et al.
MMWR. Morbidity and Mortality Weekly Report|November 15, 2019
Risk Factors for E-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products - Illinois, July-October 2019Livia Navon, Christopher M Jones, Isaac Ghinai, et al.
Gastroenterology|February 12, 2009
A mathematical model of hepatitis C virus dynamics in patients with high baseline viral loads or advanced liver diseaseHarel Dahari, Jennifer E Layden-Almer, Eric Kallwitz, et al.
Pageof 5